Akebia Therapeutics, Inc. · NASDAQ:AKBA
BlackRock, Inc. reported a 6.10% stake in Akebia Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 17, 2025
BlackRock, Inc. reported a 6.10% stake in Akebia Therapeutics, Inc., 15,141,768 shares, as a passive investor on Mar 31, 2025. Filed Apr 17, 2025 (Schedule 13G/A).
- Stake
- 6.10%
- Shares
- 15,141,768
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.10% | 15,141,768 |
Source
Related
- Akebia Therapeutics, Inc.
- BlackRock, Inc.
- Akebia Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jan 21, 2026
- Form 4 · Butler John P. · Aug 10, 2026
- Form 4 · Ostrowski Erik · Jul 1, 2026
- Form 4 · Wolf Myles · Jun 22, 2026
- Form 4 · Smith Cynthia · Jun 22, 2026
- Form 4 · Rogers Michael W · Jun 22, 2026